J V Ian Nixon

Summary

Affiliation: Virginia Commonwealth University
Country: USA

Publications

  1. ncbi request reprint Cholesterol management and the reduction of cardiovascular risk
    J V Nixon
    Division of Cardiology, Medical College of Virginia at Virginia Commonwealth University, Richmond, VA 23298 0051, USA
    Prev Cardiol 7:34-9; quiz 40-1. 2004
  2. ncbi request reprint Lower is better--the contemporary concept of low-density lipoprotein lowering in the preventive management of cardiovascular risk: does this apply to all patients?
    J V Nixon
    Division of Cardiology, Medical College of Virginia at Virginia Commonwealth University, Richmond, VA 23298 0051, USA
    Prev Cardiol 9:219-25; quiz 226-7. 2006
  3. pmc Who should receive a statin drug to lower cardiovascular risk? Does the drug and the dose of the drug matter?
    J V Ian Nixon
    Division of Cardiology, Medical College of Virginia at Virginia Commonwealth University, Richmond, VA 23298 0051, USA
    Vasc Health Risk Manag 2:441-6. 2006

Detail Information

Publications3

  1. ncbi request reprint Cholesterol management and the reduction of cardiovascular risk
    J V Nixon
    Division of Cardiology, Medical College of Virginia at Virginia Commonwealth University, Richmond, VA 23298 0051, USA
    Prev Cardiol 7:34-9; quiz 40-1. 2004
    ..Conclusions are drawn regarding the appropriate use of statin therapy in the contemporary primary and secondary preventive management of patients to reduce cardiovascular mortality and morbidity...
  2. ncbi request reprint Lower is better--the contemporary concept of low-density lipoprotein lowering in the preventive management of cardiovascular risk: does this apply to all patients?
    J V Nixon
    Division of Cardiology, Medical College of Virginia at Virginia Commonwealth University, Richmond, VA 23298 0051, USA
    Prev Cardiol 9:219-25; quiz 226-7. 2006
    ..Conclusions are drawn regarding the contemporary use of statins in the primary and secondary preventive management of patients to significantly reduce cardiovascular risk...
  3. pmc Who should receive a statin drug to lower cardiovascular risk? Does the drug and the dose of the drug matter?
    J V Ian Nixon
    Division of Cardiology, Medical College of Virginia at Virginia Commonwealth University, Richmond, VA 23298 0051, USA
    Vasc Health Risk Manag 2:441-6. 2006
    ..Available data on the use of statins in the elderly patient are reviewed, and observations are made regarding the intrinsic properties and adverse effects of the drugs...